DOI: 10.1177/00912174261474760 ISSN: 0091-2174

Early Changes in Composite Insulin-Resistance Indices After Adjunctive Probiotic Treatment in Olanzapine-Treated Schizophrenia: A Longitudinal Secondary Analysis

Cuiping Luo, Guangwei Qing, Jing Zhang, Hongfei Wan, Simin Xiong, Yuxin Zhou, Kun Yan, Yongzhi Xiong
Show PDF Cite

Objective

Olanzapine is effective for schizophrenia but commonly causes metabolic dysregulation. This study examined whether adjunctive probiotic treatment was associated with short-term changes in composite insulin-resistance-related indices during olanzapine therapy.

Methods

This longitudinal secondary analysis included 84 patients with schizophrenia receiving olanzapine: 40 received adjunctive Bifidobacterium tetravaccine live tablets and 44 received olanzapine alone. The triglyceride-glucose index (TyG), triglyceride-glucose–body mass index (TyG-BMI), metabolic score for insulin resistance (METS-IR), single-point insulin sensitivity estimator (SPISE), and triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) were assessed at baseline, Week 2, and Week 4. Baseline-adjusted linear mixed-effects models evaluated group × visit interactions and visit-specific contrasts. False discovery rate (FDR) correction and sensitivity analyses were applied.

Results

Significant group × visit interactions were observed for TyG-BMI ( P < 0.001; FDR <0.001) and SPISE ( P = 0.005; FDR = 0.012), but not for TyG, METS-IR, or TG/HDL-C. At Week 2, TyG-BMI was lower in the probiotic group (adjusted difference, −16.76; 95% CI, −23.78 to −9.74; P < 0.001; FDR <0.001), whereas SPISE was higher (adjusted difference, 0.54; 95% CI, 0.16 to 0.93; P = 0.006; FDR = 0.016). No index differed significantly between groups at Week 4.

Conclusions

Adjunctive probiotic treatment was associated with early favorable differences in TyG-BMI and SPISE, but these were not sustained at Week 4. TyG, METS-IR, and TG/HDL-C showed no significant primary-analysis effects. Larger, longer studies with direct insulin-based measurements are needed to determine reproducibility and clinical significance.

More from our Archive